Recombinant TNFRSF4 (Tavolimab Biosimilar) antibody
Quick Overview for Recombinant TNFRSF4 (Tavolimab Biosimilar) antibody (ABIN7867460)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Anti-OX40(tavolimab biosimilar) mAb
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- ELISA 1:5000-10000, Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Handling Advice
- Avoid repeated freezing and thawing,After reconstitution, if not intended for use within a month, aliquot and store at -80 °C
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.
-
Expiry Date
- 12 months
-
-
- TNFRSF4 (Tavolimab Biosimilar)
-
Alternative Name
- tavolimab biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms: TNFRSF4, TXGP1L, CD134, ACT35 antigen, OX40L receptor,MEDI0562
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P43489
Target
-